Approximately a third of the adult population worldwide has MASLD, the presence of steatosis (the accumulation of fat) in the ...

The Fatty Liver Alliance raises awareness about the risks, causes and complications of fatty liver disease and helps those already diagnosed with NAFLD and NASH by advocating for access to approved ...

Fatty liver disease is rising in Kashmir and South Asia. Learn why NAFLD is now called MASLD, its link to obesity and diabetes, risks, and how lifestyle changes can reverse early liver damage.

Imagine sitting in a doctor’s office and being told you have “non-alcoholic” liver disease. Before the doctor even finishes explaining what that means, your brain is already doing gymnastics trying to ...

TEL AVIV, Israel, June 21, 2023 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory ...

(Reuters) -Madrigal Pharmaceuticals shares jumped as much as 23% on Friday after its oral drug became the first approved treatment for a fatty liver disease known as non-alcoholic steatohepatitis ...

The incidence of fatty liver disease is on the rise and to a large extent it is as a result of the modern lifestyle. Although ...

“The qFibrosis data provide support for Rezdiffra’s potential in benefiting patients with NASH with moderate to advanced liver fibrosis by reversing fibrosis and preventing progression to more ...